Skip to content

13F-HR filed by TAKEDA PHARMACEUTICAL CO LTD

TAKEDA PHARMACEUTICAL CO LTD filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-08, with 11 holding rows worth $19,553,783.

Accession
0001395064-25-000124
Filed
2025-08-08
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2025

A holdings report, 12 entries on the cover page, a total value of $19,553,783 stated on the cover page (in dollars after the unit check, H1), rows summing to $19,553,783 with VALUE read as dollars as filed, 13F file number 028-24938. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerTakeda Vaccines, Inc. 028-24939

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HILLEVAX INC43157M102COM6,724,000$13,381,160dollars as filed
OVID THERAPEUTICS INC690469101COMMON STOCK7,531,996$2,485,380dollars as filed
Xilio Therapeutics Inc.98422T100COM1,475,121$1,002,935dollars as filed
AMERICAN WELL CORP03044L204COM CL A NEW77,733$691,050dollars as filed
EQUILLIUM INC29446K106COM1,824,977$575,233dollars as filed
SHATTUCK LABS INC82024L103COMMON STOCK515,619$408,267dollars as filed
LYELL IMMUNOPHARMA INC55083R104COM41,165$363,906dollars as filed
TURNSTONE BIOLOGICS CORP90042W100COM895,824$321,601dollars as filed
THIRD HARMONIC BIO INC88427A107COM36,835$200,014dollars as filed
RANI THERAPEUTICS HLDGS INC753018100CMN203,190$104,419dollars as filed
STANDARD BIOTOOLS INC34385P108COM16,515$19,818dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001395064-25-000124this filing2025-08-08acceptance time not in the bulk data set